Position in QGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,795,353
New position
Shares Held
44,839
first reported quarter
Ownership
0.022%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in QGEN
reported options exposure · as of Mar 31, 2026CallValue
$2,202,200
CallShares
55,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026NOMURA HOLDINGS INC holds $19,811,306 across 11 Diagnostics & Research names. QGEN ranks #2 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
60,836 | $12,166,591 | |
| 2 | QGEN |
Qiagen N.V.
This page
|
44,839 | $1,795,353 | |
| 3 | DGX |
Quest Diagnostics Inc
|
5,382 | $1,054,764 | |
| 4 | CSTL |
Castle Biosciences Inc
|
35,748 | $877,613 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
4,550 | $784,875 | |
| 6 | BLLN |
BillionToOne, Inc.
|
8,600 | $678,884 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
1,274 | $626,209 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
1,304 | $626,167 |
All Filings in QGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,202,200 | 55,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,795,353 | 44,839 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||